Nisa Investment Advisors
SCLN

Nisa Investment Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Nisa Investment Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,380
Closed -$15K – 1880
2017
Q3 		$15K Hold
1,380
– – ﹤0.01% 1629
2017
Q2 		$15K Buy
1,380
+850
+160% +$8.5K ﹤0.01% 1588
2017
Q1 		$5K Sell
530
-470
-47% -$4.69K ﹤0.01% 1815
2016
Q4 		$11K Sell
1,000
-20,000
-95% -$200K ﹤0.01% 1796
2016
Q3 		$215K Buy
21,000
+20,000
+2,000% +$218K ﹤0.01% 1204
2016
Q2 		$13K Buy
+1,000
New +$13.1K ﹤0.01% 1753

Nisa Investment Advisors's SCLN Position: Q4 2017 in Review

Nisa Investment Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 1,380 shares — an estimated $15K sold.

Nisa Investment Advisors first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $215K in Q3 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Nisa Investment Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,380 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $15K.
  • Nisa Investment Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • Nisa Investment Advisors's Sciclone Pharmaceuticals Inc position peaked at $215K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Nisa Investment Advisors's 13F filing for Q4 2017, filed 12 Jan 2018.